Avidity Biosciences Inc. (RNA)
NASDAQ: RNA
· Real-Time Price · USD
46.97
2.79 (6.32%)
At close: Oct 03, 2025, 3:59 PM
48.30
2.84%
After-hours: Oct 03, 2025, 07:56 PM EDT
6.32% (1D)
| Bid | 46.72 |
| Market Cap | 6.04B |
| Revenue (ttm) | 10.73M |
| Net Income (ttm) | -455.74M |
| EPS (ttm) | -3.56 |
| PE Ratio (ttm) | -13.19 |
| Forward PE | -9 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 48 |
| Volume | 1,422,939 |
| Avg. Volume (20D) | 3,396,498 |
| Open | 44.72 |
| Previous Close | 44.18 |
| Day's Range | 44.28 - 47.30 |
| 52-Week Range | 21.51 - 56.00 |
| Beta | 0.97 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for RNA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAvidity Biosciences Inc. is scheduled to release its earnings on
Nov 6, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
-10.1%
Avidity Biosciences shares are trading lower despi...
Unlock content with
Pro Subscription
3 weeks ago
+9.02%
Avidity Biosciences shares are trading higher after the company announced the pricing of its $600 million upsized public offering of 15 million common shares at $40 per share. Also, HC Wainwright raised its price target on the stock from $68 to $87.
